US Patent No: 8,148,497
Number of patents in Portfolio can not be more than 2000
Binding molecules capable of neutralizing rabies virus and uses thereof
Stats
-
Apr 3, 2012
Issued date -
Jul 6, 2009
filing date -
12/459,661
serial no -
In Force
status
Importance
Loading Importance Indicators...
Abstract
The invention provides binding molecules that specifically bind to rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from rabies virus. Preferably, they can be used in the post-exposure prophylaxis of rabies.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 7,579,446 Binding molecules capable of neutralizing rabies virus and uses thereof | 5 | 2006 | |
| 2009/0104,204 Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof | 5 | 2007 | |
| 2009/0169,562 Human Binding Molecules Having Killing Activity Against Enterococci and Uses Thereof | 2 | 2007 | |
| 2009/0311,265 Human binding molecules capable or neutralizing influenze virus h5n1 and uses thereof | 3 | 2007 | |
| 2008/0070,799 Binding molecules capable of neutralizing rabies virus and uses thereof | 5 | 2007 | |
| 7,740,852 Binding molecules capable of neutralizing rabies virus and uses thereof | 4 | 2007 | |
| 2010/0034,829 LIQUID ANTI-RABIES ANTIBODY FORMULATIONS | 2 | 2007 | |
| 2010/0272,724 Binding molecules capable of neutralizing rabies virus and uses thereof | 5 | 2009 | |
| 2010/0172,917 Binding molecules against SARS-coronavirus and uses thereof | 5 | 2009 | |
| 2010/0310,572 Binding molecules capable of neutralizing rabies virus and uses thereof | 4 | 2010 | |
|
|
|||
| 2010/0146,647 Antibody producing non-human mammals | 3 | 2009 | |
|
|
|||
| 7,198,291 Passenger protection apparatus | 5 | 2002 | |
|
|
|||
| 2004/0013,672 Recombinant antibodies, and compositions and methods for making and using the same | 5 | 2003 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Oct 3, 2015 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Oct 3, 2019 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Oct 3, 2023 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |